However, type 1 diabetes is very different from haemophilia, and even if insulin can be expressed successfully there are additional challenges that need to be overcome before insulin gene therapy could be considered in people with type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.